Enanta Pharmaceuticals reported $28.62M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Amgen AMGN:US $ 14585M 1716M
Anika Therapeutics ANIK:US $ 41.37M 5.61M
Arrowhead Research ARWR:US $ 195.43M 28.25M
AstraZeneca AZN:LN 22222M 709M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Enanta Pharmaceuticals ENTA:US $ 28.62M 2.01M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Insmed INSM:US $ 99.66M 18.26M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Ligand Pharmaceuticals LGND:US $ 52.5M 43.31M
Marinus Pharmaceuticals MRNS:US $ 16.69M 0.57M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Novavax NVAX:US $ 1651.52M 442.96M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
Vital Therapies VTL:US $ 14.49M 1.87M
YTE INCY:US $ 660.32M 36.44M